Skip to main content

Advertisement

Table 1 Telomere status and clinical variables in non-small cell lung cancers

From: Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status

Variable N° of cases Telomere length P and test statistic T/N ratio P and test statistic
(Kilobase pairs; mean ± standard error) (mean ± standard error)
Gender 142     
 Female 12 5.49 ± 0.69 0.274; Mann-Whitney U Test 0.83 ± 0.07 0.416; Mann-Whitney U Test
 Male 130 6.66 ± 0.28 0.94 ± 0.03
TNM stage 142  
 I 86 6.08 ± 0.29 0.204; one-way ANOVA 0.91 ± 0.03 0.442; Kruskal-Wallis test
 II 9 7.01 ± 1.37 0.96 ± 0.11
 IIIA 38 7.45 ± 0.57 1.00 ± 0.06
 IIIB 5 6.15 ± 1.55 0.85 ± 0.18
 IV 4 7.79 ± 2.84 0.80 ± 0.10
Size of the primary tumour, T 142  
 T1 22 5.54 ± 0.52 0.006; Kruskal-Wallis test 0.93 ± 0.04 0.024; Kruskal-Wallis test
 T2 91 6.32 ± 0.30 0.90 ± 0.03
 T3 22 8.84 ± 0.84 1.11 ± 0.09
 T4 7 5.75 ± 1.10 0.79 ± 0.13
Lymph node dissemination, N 142  
 N0 102 6.44 ± 0.30 0.532; Kruskal-Wallis test 0.93 ± 0.03 0.456; Kruskal-Wallis test
 N1 11 7.74 ± 1.22 1.02 ± 0.10
 N2 28 6.64 ± 0.62 0.93 ± 0.07
 N3 1 3.25 0.62
Tumour metastasis, M 142  
 Absence, M0 138 6.52 ± 0.26 0.848; Mann-Whitney U Test 0.94 ± 0.03 0.349; Mann-Whitney U Test
 Presence, M1 4 7.79 ± 2.84 0.80 ± 0.10
Histology 141a  
 Squamous cell carcinoma (SCC) 79 6.47 ± 0.33 0.128; Kruskal-Wallis test 0.94 ± 0.03 0.022; Kruskal-Wallis test
 Adenocarcinoma (AD) 56 6.93 ± 0.46 0.96 ± 0.04
 Large cell undifferentiated carcinoma (LCUC) 6 4.31 ± 0.89 0.64 ± 0.10
  1. aMissing data